Tumor Necrosis Factor Inhibition in the Acute Management of Traumatic Optic Neuropathy

PURPOSE: To determine the effectiveness of etanercept, a tumor necrosis factor (TNF) inhibitor, in conferring neuroprotection to retinal ganglion cells (RGCs) and improving visual outcomes after optic nerve trauma with either optic nerve crush (ONC) or sonication-induced traumatic optic neuropathy (...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Invest Ophthalmol Vis Sci
Autores principales: Tse, Brian C., Dvoriantchikova, Galina, Tao, Wensi, Gallo, Ryan A., Lee, John Y., Pappas, Steven, Brambilla, Roberta, Ivanov, Dmitry, Tse, David T., Pelaez, Daniel
Formato: Artigo
Lenguaje:Inglês
Publicado: The Association for Research in Vision and Ophthalmology 2018
Materias:
Eye Movements, Strabismus, Amblyopia and Neuro-Ophthalmology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5989875/
https://ncbi.nlm.nih.gov/pubmed/30025145
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1167/iovs.18-24431
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares